Work

Supplementary Data5 from RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236

Year: 2026

Type: supplementary-materials

Abstract: Clinical information of patients harboring RRAS/RRAS mutations

DOI: 10.1158/1078-0432.31910999

Authors: Alexander J. Pfeil, Tom Zhang, Ryan Cheng, Marissa S. Mattar, Juan Luis Gomez Marti, Leo Gili, Rachel Lai, Inna Khodos, Rohan P. Master, Jenna-Marie Dix, Andrea Gazzo, Kathryn C. Arbour, Elisa de Stanchina, Christopher A. Febres-Aldana, Marc Ladanyi, Soo-Ryum Yang, Romel Somwar

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W7147497595

Cites:

Cited by:

Related to: